Loss of retinoic acid receptor-β expression is an early event during esophageal carcinogenesis

American Journal of Pathology

Volumn 155, Issue 5, 1999, Pages 1519-1523

  Qiu, Hongming ^a   Zhang, Wei ^b   El Naggar, Adel K ^a   Lippman, Scott M ^a   Lin, Peizhong ^b   Lotan, Reuben ^a   Xu, Xiao Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032706665     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65467-3     Document Type: Article

References (22)

1. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980, 605:33-91
2. Moon RC, Mehta RG, Rao KVN: Retinoids and cancer in experimental animals. The Retinoids - Biology, Chemistry, and Medicine, ed 2. Edited by MB Sporn, AB Roberts, DS Goodman. New York, Raven Press, 1994, pp 537-596
3. Inayama Y, Kitamura H, Shibagaki T, Usuda Y, Ito T, Nakatani Y, Kanisawa M: In vivo growth and differentiation potential of tracheal basal cells of rabbits in vitamin A deficiency. Int J Exp Pathol 1996, 77:89-97
4. Han J: Highlights of the cancer chemoprevention studies in China. Prev Med 1993, 22:712-722
5. Blot WJ, Li JY, Taylor PR: Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combination, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst 1993, 85:1483-1492
6. Li JY, Taylor PR, Li B: Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 1993, 85:1492-1498
7. Chambon P: A decade of molecular biology of retinoic acid receptors. FASEB J 1996, 10:940-954
8. Xu X-C, Liu X, Tahara E, Lippman SM, Lotan R: Expression and up-regulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999, 59:2477-2483
9. Xu X-C, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R: Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 1994, 54:3580-3587
10. Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK: Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 1995, 332:1405-1410
11. Xu X-C, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK, Lotan R: Suppression of nuclear retinoic acid receptor β in non-small cell lung cancer in vivo: implications in lung cancer development. J Natl Cancer Inst 1997, 89:624-629
12. Xu X-C, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R: Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis. Cancer Res 1997, 57:4992-4996
13. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 1991, 51:3972-3981
14. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG: High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 1991, 6:1859-1868
15. de The H: Altered retinoic acid receptor. FASEB J 1996, 10:955-960
16. Enzinger PC, Ilson DH, Saltz LB, Martin LK, Kelsen DP: Phase II clinical trial of 13-cis-retinoic acid, and interferon-α-2a in patients with advanced esophageal carcinoma. Cancer 1999, 85:1213-1217
17. Slabber CF, Falkson G, Burger W, Schoeman L: 13-cis-Retinoic acid and interferon α-2a in patients with advanced esophageal cancer: a phase II trial. Invest. New Drugs 1996, 14:391-394
18. Houle B, Rochette-Egly C, Bradley WE: Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993, 90:985-989
19. Berard J, Laboune F, Mukuna M, Masse S, Kothary R, Bradley WEC: Lung tumors in mice expressing an antisense RAR-β2 transgene. FASEB J 1996, 10:1091-1097
20. Nakamura Y, Tokino T, Isomura M, Inazawa J, Aoki T, Mori T, Shimada M, Miura K, Suzuki K: Multistep carcinogenesis of esophageal carcinoma. Molecular Pathology of Gastroenterological Cancer. Edited by E Tahara. Tokyo, Springer-Verlag, 1997, pp 15-21
21. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang XK: Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 1996, 16:1138-1149
22. Xu X-C, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R: Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor β expression. Cancer Res 1995, 55:5507-5511